Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets
0205052X0AAAAAA
|
Valsartan/hydrochlorothiazide | Valsartan with diuretic | Cardiovascular System | 7,528 |
|
Valsartan 80mg / Hydrochlorothiazide 12.5mg tablets
0205052X0AAACAC
|
Valsartan/hydrochlorothiazide | Valsartan with diuretic | Cardiovascular System | 3,319 |
|
Valsartan 160mg / Hydrochlorothiazide 25mg tablets
0205052X0AAABAB
|
Valsartan/hydrochlorothiazide | Valsartan with diuretic | Cardiovascular System | 2,732 |
|
Co-Diovan 80mg/12.5mg tablets
0205052X0BBACAC
|
Co-Diovan | Valsartan with diuretic | Cardiovascular System | 346 |
|
Co-Diovan 160mg/12.5mg tablets
0205052X0BBAAAA
|
Co-Diovan | Valsartan with diuretic | Cardiovascular System | 332 |
|
Co-Diovan 160mg/25mg tablets
0205052X0BBABAB
|
Co-Diovan | Valsartan with diuretic | Cardiovascular System | 297 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.